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Summary
As the standard enucleation method in mammalian nuclear transfer is invasive and damaging to
cytoplast spatial organization, alternative procedures have been developed over recent years. Among
these techniques, chemically induced enucleation (IE) is especially interesting because it does not
employ ultraviolet light and reduces the amount of cytoplasm eliminated during the procedure. The
objective of this study was to optimize the culture conditions with demecolcine of pre-activated bovine
oocytes for chemically IE, and to evaluate nuclear and microtubule organization in cytoplasts obtained
by this technique and their viability. In the first experiment, a negative effect on oocyte activation was
verified when demecolcine was added at the beginning of the process, reducing activation rates by
approximately 30%. This effect was not observed when demecolcine was added to the medium after
1.5 h of activation. In the second experiment, although a reduction in the number of microtubules
was observed in most oocytes, these structures did not disappear completely during assessment.
Approximately 50% of treated oocytes presented microtubule reduction at the end of the evaluation
period, while 23% of oocytes were observed to exhibit the complete disappearance of these structures
and 28% exhibited visible microtubules. These findings indicated the lack of immediate microtubule
repolymerization after culture in demecolcine-free medium, a fact that may negatively influence
embryonic development. However, cleavage rates of 63.6–70.0% and blastocyst yield of 15.5–24.2% were
obtained in the final experiment, without significant differences between techniques, indicating that
chemically induced enucleation produces normal embryos.
Keywords: Bovine, Chemically induced enucleation, Chromatin; Microtubule, Nuclear transfer
1All correspondence to: Naiara Zoccal Saraiva. Embrapa
Amazônia Oriental, Trav. Dr. Enéas Pinheiro, s/no, Caixa
Postal 48, CEP 66095–100, Belém, PA, Brazil. Tel: +55 91 3204
1113. e-mail: naiara.saraiva@embrapa.br
2Departamento de Medicina Veterinária Preventiva e Re-
produção Animal, Universidade Estadual Paulista, Jabot-
icabal, Brazil.
3Embrapa Dairy Cattle, Valença, Brazil.
4Departamento de Medicina Veterinária, Faculdade de
Zootecnia e Engenharia de Alimentos, Universidade de São
Paulo, Pirassununga, Brazil.
5Centro APTA Bovinos de Corte, Instituto de Zootecnia,
Sertãozinho, SP, Brazil.
6Embrapa Southeast Livestock, São Carlos, Brazil.
Introduction
Somatic cell nuclear transfer has been used extensively
as a valuable tool for the production of animal clones
from adult somatic cells and for the generation of
transgenic animals for agricultural and biomedical
research. However, the frequency of early postim-
plantation developmental arrest and abortion is high,
especially in bovine (Hill et al., 2000). Biological
and technical aspects related to somatic cell nuclear
transfer may account for the limited success of the
technique; oocyte enucleation is one of the crucial
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technical steps that need to be improved. Successful
reprogramming of the donor nuclei depends on the
sufficient supply of factors in the recipient oocyte.
In this respect, any cytoplasmic alterations such as
changes in nuclear maturation status, microtubule
organization and microfilaments, or biochemical and
physiological changes can potentially affect nuclear
reprogramming and result in cloning failure (Li et al.,
2009).
The standard method of oocyte enucleation is
time consuming, technically demanding, invasive and
damaging to cytoplast spatial organization, including
the loss of molecular factors that play a key role
in subsequent oocyte activation, reprogramming of
the transferred nucleus, mitotic spindle assembly, and
early embryo development (Simerly et al., 2003; Miyara
et al., 2006; Van Thuan et al., 2006). Furthermore,
although nuclear DNA is removed during oocyte
enucleation, there is the possibility of damage to
mitochondrial DNA (Fischer-Russel et al., 2005).
Therefore, simplification of this step is constantly
a center of interest for scientists involved in the
production of clones (Fulka et al., 2004).
Chemical enucleation using microtubule-
depolymerizing drugs is an attractive procedure that
has been used to simplify conventional enucleation
methods. In chemically assisted enucleation (Yin
et al., 2002a,b), metaphase II oocytes are exposed to
an antimitotic drug and spindle depolymerization
leads to the formation of a cortical protrusion on
the surface of the oocyte that contains all oocyte
chromosomes. This protrusion can be easily removed
by micromanipulation techniques (Yin et al., 2002a) or
by oocyte bisection (handmade cloning; Vajta et al.,
2003). Anti-mitotic drugs have also been applied to
pre-activated oocytes, resulting in the extrusion of
a second polar body (PB) that contains all oocyte
chromosomes. This technique is called chemically
induced enucleation (IE).
In chemically IE, the treatment of pre-activated
oocytes with high concentrations of demecolcine
(0.4 to 0.5 g/ml), a microtubule-depolymerizing
drug, has been proven to be effective for oocyte
enucleation in mice (Baguisi & Overström, 2000;
Gasparrini et al., 2003; Ibáñez et al., 2003), goats (Ibáñez
et al., 2002), and cattle (Fischer-Russel et al., 2005).
Although mouse offspring were produced by nuclear
transfer using this protocol (Baguisi & Overström,
2000; Gasparrini et al., 2003), the percentage of
embryos that developed to blastocyst stage was much
lower among chemically enucleated nuclear transfer
embryos than in those enucleated by conventional
mechanical methods (Gasparrini et al., 2003).
To our knowledge, there has been to date only one
report using chemically IE in cattle, and in which
the authors employed intracytoplasmic injection for
embryo reconstitution (Fischer-Russel et al., 2005). An
understanding of the mechanism of chemically IE and
modifications of the current protocol would lead to an
increase in the frequency of induced enucleation and
thus minimize the invasiveness of currently employed
enucleation procedures. As further data are needed
to fine tune the dose and duration of exposure to
demecolcine in combination with modifications of the
oocyte activation protocol (Fischer-Russel et al., 2005),
the objective of the present study was to optimize
the culture conditions of bovine oocytes exposed to
demecolcine after oocyte activation in an attempt to
improve the efficiency of chemically IE, and to evaluate
tubulin and chromatin organization and the viability
of cytoplasts produced by this technique.
Material and methods
Chemicals
Chemicals and media were purchased from Sigma
Chemical Co. (St. Louis, MO, USA), unless otherwise
stated.
Experimental design
Experiment I: Evaluation of different culture conditions
with demecolcine for chemically induced enucleation
First, different experiments were conducted to stand-
ardize the chemically IE technique in bovine. Oocytes
were treated with demecolcine at the beginning
(Experiment Ia) or after the onset (Experiment Ib) of
the activation process.
Experiment Ia: Exposure to demecolcine at the beginning
of parthenogenetic activation. Oocytes matured in vitro
for 26 h were denuded and activated artificially with
ionomycin (5 M for 5 min) and cycloheximide (10
g/ml for up to 5 h). Three groups were established:
(1) a control (not activated and not treated with
demecolcine); (2) an activated (exposed only to the
oocyte-activating agents); and (3) a treated group
(DEME; exposed to the oocyte-activating agents and
0.05 g/ml demecolcine). Treatment with demecolcine
was initiated at the beginning of oocyte activation
and samples were collected in quintuplicate from
the three groups after 0, 4 or 5 h of treatment. The
oocytes were stained with 10 g/ml Hoechst 33342
for 15 min and the percentage of metaphase II oocytes
and activation and enucleation rates was determined
under an epifluorescence microscope (330–385 nm).
Experiment Ib: Exposure to demecolcine after the
onset of activation. After 26 h of in vitro maturation,
oocytes were denuded and activated as described
in Experiment Ia for up to 4 h. Control, activated
and demecolcine-treated (DEME) groups were also
defined. However, in the DEME group the activation
Chemically IE of activated bovine oocytes 3
lasted for up to 4 h and treatment with 0.05 g/ml
demecolcine was started 0, 0.5, 1.0, 1.5, or 2.0 h after
the onset of oocyte activation. Therefore, the following
subgroups were established: (1) DEME 0–2 h (exposure
to demecolcine between 0 and 2 h of activation); (2)
DEME 0–4 h; (3) DEME 0.5–2.5 h; (4) DEME 0.5–
4 h; (5) DEME 1–3 h; (6) DEME 1–4 h; (7) DEME
1.5–3.5 h; (8) DEME 1.5–4 h, and (9) DEME 2–4 h.
Quintuplicate samples were obtained. The oocytes
were stained with 10 g/ml Hoechst 33342 for 15 min
and activation and enucleation rates were determined
under an epifluorescence microscope (330–385 nm).
Experiment II: Tubulin and chromatin organization in
parthenogenetically activated oocytes submitted to
chemically induced enucleation
In the third experiment, we evaluated the effects of
demecolcine on nuclear and microtubule organization
of activated oocytes submitted to chemically IE.
For this purpose, three groups were defined as
described before (control, activated, and treated with
demecolcine–DEME). In the DEME group, activated
oocytes were exposed to the drug in the last 2 h of
activation (DEME 2–4 h group). The samples were
fixed and the configuration of chromatin and meiotic
spindle (microtubules) was evaluated in triplicate at
0, 0.5, 1.0, 2.0, 2.5, 3.0, 4.0, or 10 h after the onset of
activation.
Experiment III: Early development of embryos reconstituted
by nuclear transfer from chemically enucleated cytoplasts
In the final experiment, after chemical or conventional
enucleation, part of the cytoplasts were fixed in 4%
paraformaldehyde for 1 h at room temperature and
stored in phosphate-buffered saline (PBS) + 1% PVP
for evaluation of the efficiency of enucleation by
staining with Hoechst 33342 for 15 min and obser-
vation under an epifluorescence microscope (330–385
nm). The remaining cytoplasts were reconstituted by
nuclear transfer (NT) and presumptive zygotes were
cultured in vitro. The rates of embryo development
were determined after 48 h (cleavage) and on day 7 of
culture (blastocysts).
Oocyte recovery and in vitro maturation
Bovine oocytes were obtained by follicular aspiration
from ovaries obtained at a local slaughterhouse. The
ovaries were transported to the laboratory in 0.9%
saline solution at 30–35°C. Follicles with diameters
between 3 and 8 mm were aspirated using an 18-gauge
needle attached to a 20-ml syringe and cumulus oocyte
complexes (COCs) with at least three layers of cumulus
cells and homogenous cytoplasm were selected. The
COCs were washed in HEPES-buffered tissue culture
medium-199 (TCM-199; Gibco BRL, Grand Island, NY,
USA) supplemented with 10% fetal calf serum (FCS),
0.20 mM sodium pyruvate, and 83.4 g/ml amikacin
(Instituto Biochimico, Rio de Janeiro, Brazil). Groups of
15 COCs were matured in droplets (100 L) of TCM-
199 supplemented with 10% FCS, 1.0 g/ml FSH, 50
g/ml hCG (ProfasiTM, Serono, São Paulo, Brazil), 1.0
g/ml estradiol, 0.20 mM sodium pyruvate, and 83.4
g/ml amikacin under mineral oil (Dow Corning Co.,
Midland, MI, USA) for up to 26 h at 38.5°C in an
atmosphere of 5% CO2 in air and maximum humidity.
Isolation of nucleus donor cells
Blastomeres were used as donor nucleus cells in the
NT procedures. Cells were obtained from embryos
produced in vitro with female and male sexed semen.
The in vitro fertilization procedure was performed 24
h after in vitro maturation. For this purpose, groups
of 15 oocytes were washed twice and transferred to
30 l drops of TALP-IVF medium supplemented with
0.6% bovine serum albumin (BSA), 10 g/ml heparin,
18 M penicillamine, 10 M hypotaurine and 1.8
M epinephrine, and covered with sterile mineral oil.
Frozen straws of semen from the same bull sexed by
flow cytometry (Lagoa da Serra, Sertãozinho, Brazil)
were used. Each straw containing approximately 2
million spermatozoa was centrifuged separately on a
discontinuous 45/90 Percoll gradient for 7 min at 3600
g. The pellet was resuspended in 500 l TALP-IVF
medium and again centrifuged for 5 min at 520 g.
After centrifugation, 100 l of the medium containing
the pellet was collected from the bottom of the tube
and homogenized in a conic tube. The final suspension
was divided among 10 oocyte-containing drops, at a
final concentration of approximately 104 spermatozoa
per oocyte. The plates were incubated for 18–20 h at
38.5°C in an atmosphere of 5% CO2 under saturated
humidity. After this period, embryos were cultured
in synthetic oviductal fluid (SOF) supplemented with
2.5% FCS and 5 mg/ml BSA at 38.5°C in a humidified
atmosphere of 5% CO2 in air. Groups of 10–20 1-cell
embryos were cultured in 100 l microdrops of culture
medium for 5 days. The medium was renewed on the
third day of embryo culture.
For the isolation of blastomeres used for recon-
stitution by NT from cytoplasts enucleated by the
conventional technique, day-5 embryos were cultured
in SOF medium containing 0.4 g/ml demecolcine
for 12 h to synchronize cells in the metaphase
stage. Approximately 3 h before the beginning of
micromanipulation, the embryos were washed several
times and cultured in demecolcine-free SOF medium
so that at the time of use the cells were in G1, a stage
compatible with oocytes exhibiting high activity of
maturation-promoting factor (MPF). For the chemical
enucleation technique, in which activated oocytes
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(low MPF activity) are used, the embryos were not
synchronized as about 80% of the cells are naturally
in the S phase of the cell cycle (Campbell et al., 1996).
At the time of use, the zona pellucida was removed
from the embryos by incubation in 0.5% pronase for 30
s. Next, the embryos were transferred to microdroplets
of Ca2+- and Mg2+-free PBS containing 0.3% PVA and
disaggregated into single blastomeres with a pipette.
Blastomeres derived from early and compact morulae
were used. The blastomeres were incubated for 30 min
in 7.5 g/ml cytochalasin B and then transferred to
droplets for micromanipulation and used as donor
nucleus cells.
Nuclear transfer procedure
Oocyte enucleation techniques
For conventional oocyte enucleation, oocytes matured
in vitro for 18 to 20 h were used. After denuding with 2
mg/ml hyaluronidase, the structures were incubated
for 30 min at 38.5°C in SOF medium with HEPES
buffer (HSOF) supplemented with 10% FCS, 7.5
g/ml cytochalasin B, and 7.5 g/ml Hoechst 33342.
Enucleation was performed under an inverted light
microscope (Olympus IX-70), removing the first PB
and part of the adjacent cytoplasm. Enucleation was
confirmed by examining the oocyte under ultraviolet
light to determine the absence of the metaphasic plate.
For chemically IE, oocytes matured in vitro for
26 h were denuded and activated artificially (5 M
ionomycin for 5 min and 10 g/ml cycloheximide for
5 h). After 1.5 h of activation, the oocytes were treated
with demecolcine (0.05 g/ml) for complete extrusion
of the nuclear material of the oocyte together with
the second PB. A the end of treatment, the second
PB and a small part of the adjacent cytoplasm were
removed by micromanipulation and the cytoplasts
were subsequently used for NT.
Embryo reconstitution
Embryonic cells were individually transferred to the
perivitelline space of each recipient cytoplast and
cytoplast–cell complexes were electrofused in 0.3 M
mannitol solution containing 0.05 mM CaCl2, 0.1 mM
MgSO4 and 0.1% PVA. Electrofusion was induced by a
direct pulse of 1.5 kV/cm for 70 s (Bordignon et al.,
1999) and successfully reconstituted structures were
incubated in SOF + 10% FCS at 38.5°C in a humidified
atmosphere of 5% CO2 in air.
Parthenogenetic activation
Only reconstituted oocytes obtained by the conven-
tional technique were activated at the end of the
procedure, whereas in chemically IE oocytes were
activated at the beginning of the protocol. The oocytes
were chemically activated with 5 M ionomycin in
HSOF supplemented with 10% FCS for 5 min and with
10 g/ml cycloheximide + 10 g/ml cytochalasin B
in SOF supplemented with 10% FCS for 5 h at 38.5°C
in a humidified atmosphere of 5% CO2 in air. Next,
embryos were cultured until day 7.
Immunofluorescence analysis of tubulin and
chromatin
The protocol described by Liu et al. (1998) was
used. Briefly, oocytes were incubated for 30 min in
microtubule-stabilizing buffer (0.1 M PIPES, pH 6.9,
5 mM MgCl2.6H2O (Merck, Darmstadt, Germany),
2.5 mM EGTA) containing 2% formaldehyde, 0.1%
Triton X-100, 1 M Taxol, 0.01% aprotinin, 1 mM
dithiothreitol, and 50% deuterium oxide (Aldrich
Chem. Co., Milwaukee, WI, USA). Next, oocytes were
kept overnight at 4°C in washing medium (WM; PBS
with 0.02% NaN3, 0.01% Triton X-100, 0.2% non-fat
dry milk, 2% FCS, 2% BSA, and 0.1 M glycine) and
were then incubated in WM containing anti--tubulin
mouse monoclonal antibody (1:50) conjugated with
fluorescein isothiocyanate (FITC) for 2 h at 38°C. After
washing in WM, oocytes were stained with 10 g/ml
Hoechst 33342 in WM for 10 min, mounted on slides
with 90% glycerol in PBS, and examined under an
epifluorescence microscope at 330–385 and 420–490
nm. For the evaluation of nuclear kinetics, the oocytes
were classified as immature, metaphase II (MII) or
activated (AII/TII with extrusion of the 2nd PB or
pronucleus stage) (Fig. 1). In addition, the oocytes
were classified according to microtubule organization
(present, reduced, or absent) as described in Fig. 2.
Statistical analysis
The rates of activation, enucleation and embryo
development were analyzed by chi-squared ( 2) test or
Fisher’s exact test, when appropriate. The percentages
obtained in Experiment II were submitted to analysis
of variance (ANOVA) and means were compared
by the Tukey test. All analyses were performed
using Statistical Analysis System (SAS) 9.1 software,
adopting a level of significance of 5%.
Results
Addition of demecolcine at the beginning of
parthenogenetic activation
At the beginning of assessment (0 h), most oocytes
were at the MII stage (133/163, 81.6%). A significant
increase in the percentage of oocytes with extrusion of
the second PB was observed in the groups activated for
4 or 5 h. These groups did not differ from one another
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Table 1 Percentage of metaphase II (MII), activated, and enucleated (EN) oocytes in the control group (CON),
group activated with 5 M ionomycin for 5 min and 10 g/ml cycloheximide (ACTIV), and group activated
and treated with 0.05 g/ml demecolcine (DEME) for 0, 4 and 5 h
Time (h) Treatments MII (%) Activated (%) EN (%) Total
0 – 133 (81.6)a 02 (1.3)c 01 (0.6)c 163
4 CON 121 (80.7)a 04 (2.7)c 0c 150
ACTIV 31 (19.6)b 97 (61.4)a 07 (4.4)b 158
5 DEME 26 (17.7)b 53 (36.0)b 58 (39.4)a 147
CON 126 (79.2)a 05 (3.1)c 0c 159
ACTIV 34 (21.6)b 100 (63.7)a 13 (8.3)b 157
DEME 29 (18.9)b 47 (30.7)b 64 (41.8)a 153
a ,b,cValues with different superscript letters within the same column differ (P < 0.05, chi-squared test).
Figure 1 Evaluation of nuclear kinetics. Photomicrographs of activated bovine oocytes treated with demecolcine. Categories
of oocytes observed: (a) metaphase I (MI) oocyte; (b) metaphase II (MII) oocyte; (c) anaphase/telophase II (AII/TII) oocyte.
Oocytes were stained with Hoechst 33342 and observed under an epifluorescence microscope. The arrows indicate nuclear
material (blue). Bar = 50 m.
Figure 2 Evaluation of microtubule configuration. Photomicrographs of activated bovine oocytes treated with demecolcine.
Categories of oocytes observed: (a) oocyte with microtubules (MTs); (b) oocyte with reduced MTs; (c) oocyte without MTs.
Oocytes were stained with FITC-conjugated anti- tubulin antibody (1:50) and observed under an epifluorescence microscope.
The arrows indicate MTs (green). Bar = 50 m.
and the percentage of oocytes was higher than in the
groups treated with demecolcine (Table 1).
Enucleation rates were higher in the DEME group
(P < 0.05) than in the control and activated groups
after 4 and 5 h of activation (Table 1), which also
differed from one another. However, demecolcine
probably interfered with oocyte activation, resulting
in low enucleation rates (39.4–41.8%). No significant
difference was observed between groups treated with
demecolcine for 4 and 5 h (Table 1).
Addition of demecolcine after the onset of
parthenogenetic activation
Demecolcine exerted no damaging effects on oocyte
activation when added to the medium 1.5 h after
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Table 2 Percentage of activated oocytes after incubation in
medium containing 5 M ionomycin for 5 min and 10 g/
ml cycloheximide for 4 h and different times of treatment
with demecolcine: DEME 0–2 h (exposure to demecolcine
between 0 and 2 h of activation); DEME 0–4 h; DEME 0.5–
2.5 h; DEME 0.5–4 h; DEME 1–3 h; DEME 1–4 h; DEME
1.5–3.5 h; DEME 1.5–4 h; DEME 2–4 h
Treatments Activated (%) Total
CON 01 (0.9)∗ 114
ACTIV 97 (74.6)a ,b 130
DEME 0–2 h 42 (38.9)∗ 108
DEME 0–4 h 36 (32.7)∗ 110
DEME 0.5–2.5 h 59 (54.1)∗ 109
DEME 0.5–4 h 56 (48.7)∗ 115
DEME 1–3 h 69 (59.0)∗ 117
DEME 1–4 h 62 (55.8)∗ 111
DEME 1.5–3.5 h 64 (62.7)a 102
DEME 1.5–4 h 76 (69.7)a ,b 109
DEME 2–4 h 87 (77.0)b 113
∗The asterisk indicates difference in relation to activated
group.
a ,bValues followed by the same letter between rows did not
differ significantly (P > 0.05, chi-squared test).
ACTIV: activated group; CON: control group.
the beginning of the process, with no significant
differences (P > 0.05) between the DEME 1.5–3.5 h,
DEME 1.5–4 h or DEME 2–4 h groups and the group
submitted to activation only (mean of 62.7–77.0%)
(Table 2).
Enucleation rates differed significantly between all
groups treated with demecolcine and the control
(0/114) and activated (0/130) groups (Fig. 3). The
DEME 1.5–4 h (42.2%) and DEME 2–4 h (54.0%) groups
presented higher enucleation rates (P < 0.05) than all
other groups (26.8–36.3%), but there was no difference
between these two groups. As the percentage of
activated and enucleated oocytes was higher in the
DEME 2–4 h group, this treatment was chosen for the
following experiments.
Evaluation of nuclear and microtubule kinetics in
pre-activated oocytes treated with demecolcine
The frequency of immature oocytes was similar
in the three groups (control, activated and DEME)
throughout the period of evaluation (Fig. 4). Effects
of activation were detected after 2 h, when the mean
percentage of activated oocytes was higher in the
activated and DEME groups in comparison to the
control group (Fig. 4).
The percentage of oocytes with microtubules was
significantly reduced (P < 0.05) in the DEME group
when compared with the activated group 2.5 h after
the onset of activation (0.5 h of exposure to demecol-
cine). After 10 h, lower mean percentages of oocytes
with microtubules were observed in the activated and
DEME groups compared to control and this percentage
also differed between the first two groups (Fig. 5). In
parallel, there was a significant increase (P < 0.05) of
oocytes with reduced microtubules in the DEME group
2.5 h after the onset of activation. This higher mean
percentage was observed up to 4 h after the onset of
activation when compared to the control and activated
groups (Fig. 5).
Microtubule reduction was observed in approx-
imately 50% of oocytes of the DEME group 10 h
after the onset of activation. However, no significant
difference was observed between the treated and
activated groups, only when compared with the
control group. In addition, 23% of oocytes displayed
absent microtubules in the DEME group, a mean value
higher than that observed in the control and activated
groups (P < 0.05) (Fig. 5).
Early development of embryos reconstituted by
nuclear transfer from cytoplasts produced by
chemically induced enucleation
In relation to cleavage and blastocyst rates, no
significant differences were observed between groups
(P > 0.05) despite a tendency towards lower embryo
production in the chemically enucleated group. As no
significant difference was observed between sexes, the
results of female and male embryos were pooled for
each technique (Table 3).
Discussion
First, oocytes were exposed to demecolcine at the start
of activation. However, as the enucleation rates were
relatively low (39.45–42.38%), a second experiment
was conducted in which demecolcine was added
after the onset of oocyte activation and higher
enucleation rates were obtained. No damaging effect
of demecolcine on oocyte activation was observed
when treatment was started 1.5 h after the exposure
of oocytes to the activating agents, with a mean
enucleation rate of 54%. Similar findings have been
reported by Ibáñez et al. (2003) and Fischer-Russel
et al. (2005) for mouse and bovine oocytes, respectively,
and can be explained by the fact that demecolcine
impairs spindle rotation in activated oocytes, an event
that normally precedes formation of the PB. Thus,
the beginning of demecolcine treatment in relation
to oocyte activation is the key point for successful
enucleation. The present results agree with previous
studies showing that an intact spindle is required
for the degradation of cyclin B and the consequent
inactivation of MPF and exit from the M phase (Kubiak
et al., 1993).
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Table 3 Number and percentage of cleaved embryos and blastocysts
produced by nuclear transfer from donor embryo cells after
conventional or chemically induced enucleation in bovine
Treatments No. fused No. cleaved (%) No. blastocyst (%)
Conventional 66 42 (63.6) 16 (24.2)
Chemical-induced 90 63 (70.0) 14 (15.5)
No significant differences were observed between groups (P > 0.05,
chi-squared test).
Figure 3 Graphic representation of the percentage of enucleated oocytes (EN) after activation with 5 M ionomycin for 5 min
and 10 g/ml cycloheximide for up to 4 h and different treatments with demecolcine: group 1 (DEME 0–2 h); group 2 (DEME
0–4 h); group 3 (DEME 0.5–2.5 h); group 4 (DEME 0.5–4 h); group 5 (DEME 1–3 h); group 6 (DEME 1–4 h); group 7 (DEME
1.5–3.5 h); group 8 (DEME 1.5–4 h); group 9 (DEME 2–4 h). a–dColumns followed by different superscript letters differ from
one another (P < 0.05, chi-squared test). ACTIV: activated group; CON: control group.
The enucleation rates obtained in the present study
were lower than those reported by Fischer-Russel
et al. (2005) for activated bovine oocytes treated with
demecolcine (up to 91.7%). However, the high rates
reported by these authors were obtained 5 h after
the onset of oocyte activation. A new assessment
performed 17 h after the onset of activation showed
a decline in enucleation, with rates ranging from 3.4–
46.1%. These findings indicate that the chromosomes
were reintegrated into the oocyte after incomplete
extrusion of the second PB, demonstrating the
inefficiency of the enucleation process in the absence
of micromanipulation of these structures.
In this study, several oocytes contained subcortical
nuclear material which was connected to the chro-
mosomes present in the PB by a spindle remnant,
a feature also observed in activated mouse oocytes
(Ibáñez et al., 2003). These oocytes were considered
to be non-enucleated. Incomplete release of the PB
may have occurred in these treated oocytes as a
consequence of the lack of intact microtubules for the
formation of contractile rings, which are responsible
for cytokinesis (Larkin & Danilchik, 1999). However,
since this material is juxtaposed to the PB, the latter can
be easily removed by micromanipulation, facilitating
the enucleation procedure and promoting an increase
of oocyte enucleation rates. In addition, we found that
exposure to demecolcine can be interrupted after 1
h of treatment, contributing to the optimization of
the current protocol, which recommends treatment for
2 h (Fischer-Russel et al., 2005), reducing the time of
exposure to the drug.
After optimization of the chemical enucleation
protocol, we analyzed chromatin and microtubule
kinetics in these activated oocytes treated with
demecolcine. Previously our group observed that in
MII bovine oocytes, the microtubule-depolymerizing
action of demecolcine occurred after only 0.5 h
of treatment, with the complete absence of these
structures in most of the oocytes analyzed (Saraiva
et al., 2009). Different results were obtained in the
present study for pre-activated oocytes. Although the
density of microtubules was reduced in these oocytes,
complete disappearance of these structures was not
seen in most of them. Similar results have been
reported for mouse oocytes in which microtubules
also had not disappeared completely even after 2 h of
treatment with demecolcine (Ibáñez et al., 2003).
The rapid effect of demecolcine on metaphase II
oocytes (Saraiva et al., 2009), in which microtubules
disappeared completely within 0.5 h of treatment, is
likely to reflect differences in the sensitivity of the
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Figure 4 Graphic representation of nuclear kinetics in activated bovine oocytes treated with demecolcine and evaluated at
intervals of 0.5 and 1.0 h between 0 and 10 h after the onset of activation. Control (not activated or treated with demecolcine);
Activated (exposed only to the oocyte-activating agents); DEME (activated and treated with demecolcine for 2 h). (A) Immature
oocytes; (B) mature oocytes; (C) activated oocytes. The asterisk indicates exposure to demecolcine.
meiotic spindle of these structures, with the spindle
of metaphase II oocytes being a more sensitive target
for demecolcine than the spindle of activated oocytes.
The presence of these spindle remnants may indicate
differences in the stability of some microtubules in
the spindle, which probably correspond to interpolar
microtubules (Combelles & Albertini, 2001).
In the present study, reduction of microtubules was
observed in approximately 50% of treated oocytes at
the end of assessment and complete disappearance
of these structures in 23%, with visible microtubules
being seen in only 27% of oocytes. These findings
indicate the absence of immediate repolymerization
of microtubules after culture of pre-activated oocytes
in demecolcine-free medium, in contrast to metaphase
II oocytes, as evaluated previously by our group
(Saraiva et al., 2009). This fact may have some
negative consequences for subsequent embryonic
development as microtubules are important during the
first cleavages. However, a reduction of microtubule
density was also observed in oocytes of activated
group 10 h after the onset of the process, suggesting
that this reduction is a ‘physiological’ process.
It is important that future research also assesses the
behaviour of microfilaments during treatment with
demecolcine, especially in cases of pre-activated oo-
cytes. Demecolcine-induced enucleation requires the
artificial activation of the oocyte prior to its exposure to
the microtubule-destabilizing drug. Parthenogenetic
activation of bovine oocytes can be achieved by using
compounds that increase intracellular calcium, such as
ionomycin (calcium ionophore), followed by treatment
for several hours with the protein synthesis inhibitor
CHX, which induces the resumption of meiosis by
Chemically IE of activated bovine oocytes 9
Figure 5 Graphic representation of microtubule kinetics in activated bovine oocytes treated with demecolcine and evaluated at
intervals of 0.5 and 1.0 h between 0 and 10 h after the onset of activation. Control (not activated or treated with demecolcine);
Activated (exposed only to the oocyte-activating agents); DEME (activated and treated with demecolcine for 2 h). (A) oocytes
with microtubules; (B) oocytes with reduced microtubules; (C) oocytes without microtubules. The asterisk indicates exposure
to demecolcine.
inactivation of MPF and mitogen-activated protein
kinase (MAPK) (Fischer-Russel et al., 2005). Recently,
Vasilev et al. (2012) observed that artificial elevation of
intracellular Ca2+ levels with ionomycin immediately
led to drastic alteration of the actin cytoskeleton in the
immature oocytes, which exhibited depolymerization
of the actin meshwork in the subplasmalemmal
regions along with highly enhanced polymerization
and bundling of the actin filaments in the inner
cytoplasm.
As demonstrated in the sea urchin, zygote cell
cleavage depends heavily on the regulation of the
actin cytoskeleton (Dales & De Santis, 1981). Hence,
actin is intimately implicated in fertilization and in the
early stages of development. These alterations led to
difficulties in cell cleavage in the monospermic zygotes
and eventually to a higher rate of abnormal devel-
opment. Then, further studies are needed to better
characterize the mechanism of demecolcine-induced
enucleation of preactivated oocytes, considering the
involvement of microfilaments on the subsequent
embryonic development. In this context, Meng et al.
(2011) observed that in bovine MII oocytes, the
microtubules were concentrated to form the normal
spindle structure with microfilaments distributed
uniformly in the cytoplasm, while in the demecolcine-
treated oocytes, the spindle microtubules were nearly
depleted by demecolcine, but the microfilaments
were hardly affected. The demecolcine treatment
seemed to have altered the balance between the
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interaction of microtubules and microfilaments in the
treated oocytes, which appears to be the result of
the cytoplasmic protrusion. Without the aid of the
microtubules, the chromosomes were compressed by
the microfilaments to form a protrusion on the oocyte
membrane.
Evaluation of embryonic development showed
cleavage rates ranging from 63.6–70.0% in the groups
reconstituted by the different techniques. Blastocyst
rates ranged from 15.5–24.2%. Although embryo
production tended to be lower for oocytes obtained by
chemically IE, no significant differences were observed
when compared with the conventional procedure.
There are various factors that justify the use of
demecolcine for NT. According to Simerly et al.
(2003, 2004), removal of the meiotic spindle during
conventional enucleation seems to be responsible for
the low development of embryos reconstituted from
somatic cells in primates, since the centrosome and
some motor proteins, such as NuMA and KIFC1,
which are fundamental for the formation of the spindle
poles during mitosis, are depleted from the ooplasm,
resulting in spindle dysfunction and aneuploid em-
bryos. In addition, traditional mechanical enucleation
has been shown to reduce the amount of spindle-
associated  -tubulin in mouse oocytes (Van Thuan
et al., 2006). Within this context, alternative methods
of oocyte enucleation may permit the preservation of
spindle-associated factors in enucleated oocytes and
consequently improve embryo quality.
Cloned mammalian species have been produced
from either demecolcine-assisted (Yin et al., 2002a;
Kawakami et al., 2003; Vajta et al., 2003; Tani et al., 2006)
or demecolcine-induced enucleated oocytes (Baguisi &
Overström, 2000; Gasparrini et al., 2003) reconstituted
with somatic or embryonic stem cells. The only
report of demecolcine-induced enucleation in bovine
(Fischer-Russel et al., 2005) showed that intracytoplas-
mic injection of the donor nucleus prior to oocyte
activation and treatment with demecolcine or after
1.5 and 2.0 h post-activation yielded 19 and 15.7% of
blastocysts, respectively. For both treatments, cleavage
and blastocyst rates were similar to those observed
for the control group (26.1%). These data agree
with the present results, indicating that demecolcine-
induced enucleation does not compromise embryo
development in cattle.
In summary, we optimized the chemically IE
protocol and showed that the procedure may be
shortened. However, demecolcine impaired meiotic
progression when it was added to the medium during
the onset of the activation process. Furthermore,
demecolcine reduced microtubule density in pre-
activated oocytes, but these structures did not
disappear completely in most oocytes, and apparently
there was no immediate repolymerization of micro-
tubules after culture in demecolcine-free medium.
Nevertheless, the chemically IE technique permitted
to obtain viable cytoplasts for NT, providing results
similar to those observed for the conventional method.
Studies evaluating the ability to establish pregnancy
and to produce live offspring are needed to confirm
the use of demecolcine-induced enucleation in bovine.
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